Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 44Glioma 16Melanoma 11Central Nervous System Neoplasms 11Astrocytoma 11Brain Neoplasms 10Oligodendroglioma 7Gliosarcoma 5Small Cell Lung Carcinoma 4Recurrence 3Lymphoma 3Leiomyosarcoma 3Sarcoma 2Neoplasms, Neuroepithelial 2Neoplasms 2Neoplasm Metastasis 2Ependymoma 2Diffuse Intrinsic Pontine Glioma 2Breast Neoplasms 2Uveal Melanoma 1Seizures 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrent Extensive Stage Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pituitary Neoplasms 1

Interventions

Vorinostat 1Temozolomide 1Interleukin-12 1Aminolevulinic Acid 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neuroectodermal Tumors × Temozolomide × Clear all
NCT04388033 2020-06-09

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Unknown
10 enrolled
CNS

Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Neoplasms, Neuroepithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡